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Anaemia is an increasingly recognized health problem in Africa, particularly in infants and
pregnant women. Although malaria is known to be the main risk factor of anaemia in both
groups, the consequences of maternal factors, particularly malaria in pregnancy (MiP), on
infant haemoglobin (Hb) concentrations during the first months of life are still unclear.
Methods
We followed-up a cohort of 1005 Beninese pregnant women from the beginning of pregnan-
cy until delivery. A subsample composed of the first 400 offspring of these women were se-
lected at birth and followed until the first year of life. Placental histology and blood smear at
1st clinical antenatal visit (ANC), 2nd ANC and delivery were used to assess malaria during
pregnancy. Infant Hb concentrations were measured at birth, 6, 9 and 12 months of age. A
mixed multi-level model was used to assess the association between MiP and infant Hb var-
iations during the first 12 months of life.
Results
Placental malaria (difference mean [dm] = - 2.8 g/L, 95% CI [-5.3, -0.3], P = 0.03) and mater-
nal peripheral parasitaemia at delivery (dm = - 4.6 g/L, 95% CI [-7.9, -1.3], P = 0.007) were
the main maternal factors significantly associated with infant Hb concentrations during the
first year of life. Poor maternal nutritional status and malaria infection during infancy were
also significantly associated with a decrease in infant Hb.
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Conclusion
Antimalarial control and nutritional interventions before and during pregnancy should be
reinforced to reduce specifically the incidence of infant anaemia, particularly in Sub-
Saharan countries.
Introduction
TheWorld Health Organization (WHO) has estimated that over 50% of children less than 4
years are anaemic in developing countries [1]. Iron deficiency is probably the most important
cause but other nutrient deficiencies, malaria, intestinal parasitic infections, and chronic infec-
tions such as HIV also play an important role in low income countries. Malaria in pregnancy
(MiP), a commonplace disease in these areas [2], is the main risk factor for anaemia during ges-
tation, with the most important negative impact on maternal haemoglobin (Hb) observed in
primigravidae [3].
In Africa, very few studies have focused on the effects of maternal factors during pregnancy
on postnatal child’s health. Although the risk factors of anaemia in childhood are fairly well
known [4–7], the influence of gestational factors such as maternal haematological parameters,
nutritional status and history of infections occurring during gestation on the infants’Hb con-
centrations during the first year of life have been poorly explored.
On the occasion of a multi-center trial of Intermittent Preventive Treatment in Pregnancy
(IPTp) comparing sulfadoxine-pyrimethamine and mefloquine (MiPPAD study “Malaria in
Pregnancy Preventive Alternative Drugs”) [8], we had the opportunity to follow a cohort of
1005 pregnant women with the objective to study anaemia during pregnancy and its conse-
quences, APEC study (Anaemia in Pregnancy: Etiology and consequences). The first 400 chil-
dren of these women were followed-up to investigate the impact of different maternal factors in
pregnancy especially MiP on infant Hb variations during the first year of life in southern Benin.
Materials and Methods
Study design
Prospective cohort study, set-up between January 2010 and May 2012 to follow pregnant
women from the first antenatal clinical visit (1st ANC) to delivery in the framework of the MiP-
PAD clinical trial. The first 400 infants to be delivered from these women, were enrolled from
January 2010 until June 2011 and followed throughout the first year of life.
Study site and population
The study was conducted in two maternity clinics (Attogon and Sékou) in the district of Allada,
a semi-rural area located 50 km north of Cotonou and the economic capital of Benin. Allada
district is characterized by a subtropical climate and malaria is hyperendemic with an average
of 20.5 infected anopheles bites/person/year [9]. Plasmodium falciparum is the predominant
species transmitted (97%).
The study population was composed of HIV—negative pregnant women and their children
residing in the district of Allada. Twin pregnancies, pregnancies complicated by stillbirth or
fetal abnormalities have been excluded. IPTp was administered according to the clinical trial
protocol and the details are presented elsewhere [8]. Briefly, two doses of IPTp (1,500/75 mg of
sulfadoxine-pyrimethamine or 15 mg/kg of mefloquine per dose) were administered at ANC
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visits. The second dose of IPTp was given at least 1 month apart from the first dose. Clinical
malaria episodes were treated with oral quinine or arthemether-lumefantrine in first and sub-
sequent trimesters, respectively, for uncomplicated malaria, and with parenteral quinine in
case of severe malaria. Children with clinical malaria were also treated with arthemether-lume-
fantrine according to the national malaria control program guidelines and in case of severe ma-
laria, they were referred to the district hospital. Each woman received a long-lasting
insecticide-treated net that was replaced in case of damage or loss during the follow-up. They
were also systematically given 600 mg of mebendazole at 1st ANC to be taken at home (100 mg
twice day for 3 days) according to the guidelines of the Beninese Ministry of Health. In addi-
tion, supplements of oral ferrous sulfate (200 mg/day) and folic acid (5 mg/day) were given to
the pregnant women to be taken at home. Pregnant women with a Hb concentration below
110g/L were treated according to the severity of anaemia (i.e., 200 mg oral ferrous sulfate twice
day for mild and moderate anaemia (Hb level between 70 and 110 g/L) and referred to the dis-
trict tertiary hospital in case of severe anaemia (Hb< 70 g/L)). Mild or moderate infant anae-
mia was treated with 10 mg/kg/day of iron syrup for two months. Children with severe
anaemia were also referred to the district tertiary hospital for blood transfusion. Infant with
positive stool test were treated with mebendazole syrup (100 mg twice day for 3 days). All the
medications prescribed to the women and the children during their participation in the study
were free of charge.
Study procedures
Clinical data collection. After obtaining informed consent, we collected sociodemo-
graphic and socioeconomic characteristics of participants at enrolment. At the 1st ANC,
women were examined and gestational age, middle upper arm circumference (MUAC), weight
and height were recorded. This information, except for height, was also collected at 2nd ANC
and delivery. Gestational age was determined from fundal height measurement by bimanual
palpation and following McDonald's rules [10]. Weight and height in pregnant women were
respectively measured to the nearest 0.1 kg using an electronic scale (Seca corp., Hanover, MD)
and to the nearest 0.1 cm by using a bodymeter device (Seca 206 Bodymeter; Seca corp.). These
parameters were measured by two nurses, and the mean of two measurements was calculated.
At birth, newborn’s sex, weight, length, head circumference and axillary temperature were
collected. Weight was measured using an electronic baby scale (SECA type 354) with a preci-
sion of 10 g and length was measured to the nearest 1 mm with a locally manufactured wooden
measuring scale according to the criteria recommended by WHO. At the 6, 9 and 12 months
scheduled visits, the history of fever within the previous 24 hours, malaria treatment or hospi-
talization since the last visit and use of insecticide-treated nets were recorded (Fig 1).
Blood and stool sample collection. At 1st ANC, 2nd ANC and delivery, 8 mL of mother’s
venous blood was collected. The same volume was also collected on cord blood at birth and on
infant's venous blood at 6, 9 and 12 months of life. All these samples were used to look for ma-
laria parasitaemia, to determine C-reactive protein (CRP), micronutrient (serum ferritin, folic
acid and vitamin B12) and Hb concentration and to genotype Hb. At delivery, samples (biopsy
and impression smear) were collected from the placenta for parasitological evaluation. A con-
tainer was also given to the woman to collect infant’s stools in search of intestinal helminths.
On unscheduled visits, Hb dosages and thick blood smears were performed in infants with clin-
ical signs of malaria (history of fever in the last 24 hours or temperature 37.5°C and pallor).
Laboratory methods. The Hb level was measured with a Hemo-Control photometer (EKF
Diagnostics, Magdeburg, Germany) device. Daily calibration of the Hemo-Control device was
performed by laboratory technicians. In addition, an external quality control was made by
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sending one of 10 consecutive samples to the Allada Central Hospital laboratory, where dos-
ages were assessed using a hematology analyzer (Erma Laboratory, Tokyo, Japan). Hb geno-
types were determined by alkaline electrophoresis on cellulose acetate (Helena laboratories,
Beaumont, TX).
Serum ferritin, folic acid, and vitamin B12 concentrations were measured using a microparti-
cle enzyme and fluorescence polarization immunoassay (AxSym Immuno-Assay Analyzer, Ab-
bott Laboratories). CRP concentration was determined by rapid slide test (CRP Latex; Cypress
Diagnostics Inc.) to correct the effect of inflammatory syndromes on ferritin concentrations.
The Determine (HIV1 and 2 kit; Abbott Laboratories) and Bioline (HIV1 and 2 3.0 kit; Bio-
line, Taunton, MA) rapid tests were used to detect HIV infections using a serial testing algorithm.
The Lambaréné technique was used to analyze peripheral malaria infection in blood smears.
It consists of spreading a calibrated 10 μL amount of blood on a slide’s rectangular area of 1.8
cm² (1.8 x 1 cm). The slide was stained with Giemsa and read at a magnification of
1,000 × with an oil immersion lens. A multiplication factor was applied to the average parasite-
mia/field to determine the number of parasites/μL. The Lambaréné method detection threshold
has been estimated to be 5 parasites/μL [11,12].
Placental biopsies (2.5 x 2.5 cm3), collected at delivery for histology assessment, were im-
mediately put in 50 ml of 10% buffered formalin. It was then stored at 4°C in a refrigerator
until the placental tissue was processed at the pathology department. The maximum delay
before fixation was of 5 days. Placental malaria infection was defined as the presence of para-
sites with /without pigment or pigment confined to fibrin in the histological examination
[13]. Placental histology was examined without knowledge of the peripheral blood smears
results. In addition, an external quality control was made on 100% of positive slide and 10%
Fig 1. Study procedures. During follow-up, socio-demographic, economic, clinical and biological data were collected in mothers at 1st antenatal clinical visit
(ANC), 2nd ANC and delivery. The same data were also recorded in infants at birth, 6, 9 and 12 months of life. Outside of scheduled visit, haemoglobin
concentration and blood smear were performed when malaria signs were present.
doi:10.1371/journal.pone.0129510.g001
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of negative slide in reference laboratory to Barcelona Centre for International Health Re-
search (CRESIB), Hospital Clínic-Universitat de Barcelona.
Infestations by helminths were assessed by using the Kato-Katz concentration method (Ves-
tergaard Frandsen, Lausanne, Switzerland).
Definitions
Anaemia. Gestational anaemia was defined as a Hb concentration below 110 g/L [14]. In chil-
dren, it was defined by Hb level below 140 g/L at birth [15] and below 110 g/L from 6 months
[14]. Severe, moderate, and mild anaemia were respectively defined as Hb concentrations less
than 80 g/L, between 80 and 99 g/L, and between 100 and 109 g/L. Maternal anaemia was also
assessed by number of anaemia episodes during pregnancy and in purpose pregnant women
have been classified into 4 groups: (1) women not presenting any episode of anaemia during
pregnancy (either at inclusion, at the second antenatal visit or at delivery); (2) women present-
ing a single episode; (3) women with two episodes and (4) pregnant women constantly anaemic
(anaemia at each of the 3 blood assessments).
Iron status and iron deficiency anaemia (IDA). Iron deficiency (ID) was defined as a serum
ferritin concentration less than 12 μg/L or as serum ferritin concentration of 12–70 μg/L in the
context of inflammatory syndrome (CRP concentration 6 mg/mL) [16]. Anaemia associated
to ID determined IDA.
Folic acid and vitamin B12 deficiencies. Folic acid and vitamin B12 deficiencies were respec-
tively defined as a serum folic acid concentration less than 6 ng/mL and a vitamin B12 serum
concentration less than 150 pg/mL [17].
Helminth infestations. Intestinal helminth infestations were diagnosed by the presence of in-
testinal helminth eggs in the stool sample. Eggs were counted as number of eggs per g of stool.
Estimation of pre-pregnancy body mass index (BMI). All pregnant women included in the
study had a gestational age less than 28 weeks. From the end of the first trimester of gestation,
it was estimated that pregnant women gained on average 1 kg per month until delivery [18].
We used the gestational age at inclusion to estimate approximately the weight that women
were supposed to have gained since the beginning of the pregnancy. This amount was then
subtracted from the weight on the day of inclusion to obtain a rough estimate of the weight be-
fore pregnancy. BMI was calculated as the weight in kilograms divided by the square of the
height in meters (kg/m²) and we used WHO criteria to classify the women in normal BMI,
thinness (severe, moderate, mild), overweight and obesity [19].
Socio-economic index of family. This index was obtained from a synthetic score given by the
sum of the following binary variables: having gainful activity, electricity, television, refrigerator
and at least a bicycle. The total score was graded between 0 and 5. Low, average, high socio-eco-
nomic indexes were defined as synthetic score 1, between 2–3, and 4, respectively.
Data management and statistical analysis
Data were double-entered into Microsoft Access 2003 database and analyzed with Stata 12.0
Software for Windows (Stata Corp, College Station, TX). Infant Hb concentration (g/L) was
the main outcome variable in our study. Malaria infection during pregnancy (either placental
infection or peripheral parasitaemia) was the main exposure variable. We used the following
co-variables in mothers: age (years), ethnic group, socio-economic index, gravidity, gestational
age (weeks), number of antenatal visits, BMI, maternal anaemia, iron, folic acid, and vitamin
B12 deficiencies, marital status, education level. In the infants, we considered: age (months),
sex, low birthweight ((LBW), weight< 2500 g), preterm birth (gestational age< 37 weeks),
fever (temperature 37.5°C), inflammation syndrome, stunting (length-for-age z-score<
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-2SD), wasting (weight-for-length z-score< -2SD), malaria and helminth infections, sickle cell
disease, serum ferritin, folic acid and vitamin B12 concentrations.
We first described the general characteristics of the women at delivery and their children at
birth, 6, 9 and 12 months. The variations in the distribution of Hb levels between 0, 6, 9 and 12
months were assessed by a Kruskal-Wallis test. Proportions were compared with a Fisher exact
test. At each time point (birth, 6, 9 and 12 months), infant Hb levels were compared with Stu-
dent's t-test or Mann-Withney non-parametric test as appropriate.
Then, we assessed the effect of MiP on infant Hb at birth using multivariable linear regres-
sion. Afterwards, we used a longitudinal approach to take into account Hb variations over
time and to estimate the impact of MiP on infant Hb throughout the first year of life. Assum-
ing that successive Hb measurements in the same infant were correlated, the data presented a
hierarchical two-level structure, where Hb measurements (level 1) were clustered within in-
fants (level 2) [20]. Therefore, a linear mixed model with a random intercept was built as
specified in the equation below:
HaemoglobinðijÞ ¼ b00 þ
Xn
q ¼ 1 bq0 Xqj þ U0j þ eij
where haemoglobin (ij) is the ith Hb measurement of infant j, β00 is the intercept, Xqj is the q
explicative variable of infant j and βq0 its associated coefﬁcient, u0j is the random intercept
corresponding to the infant-to-infant variation in Hb level [u0j —N (0, π00)], and eij is the re-
sidual variation [eij—N(0, σ²)]. Fixed effects parameters were estimated using the maximum
likelihood method, and variance components were estimated using the restricted maximum
likelihood method. To take into account the numerous physiological changes and the non
linear evolution of Hb during the ﬁrst 3 months of life, we excluded the ﬁrst Hb measurement
(at birth) from the hierarchical mixed model. Also, we adjusted our longitudinal analysis on
the hematological parameters of the newborn such as iron or folic acid deﬁciencies at birth
that could modify the levels of Hb during the ﬁrst year of life. All variables with P values
below 0.2 in univariate analysis and which were not in the causal pathway between placental
malaria and infant Hb, were included in multivariate analyses. Manual backward selection
procedure was performed and statistical signiﬁcance was set at P< 0.05. For variables with
more than two categories, P value of the global test is given.
Ethics statement
This study was approved by the Ethics Committee of the Health Sciences Faculty of Cotonou
in Benin. Before each inclusion, all participants involved in our study provided their written in-
formed consent to participate in this study. The study was also explained in the local language
to the participant, and her voluntary consent was obtained. In case the woman could not read,
an impartial witness was involved in the process. Mothers were free to interrupt their participa-
tion at any time in the study.
Results
Study profile
Between January 2010 and June 2011, 400 mother-infant pairs were enrolled in the study. The
proportion of lost to follow-up during the whole study period was 1.2% (Fig 2). Hb was respec-
tively assessed in 100% (400 of 400), 88.4% (312 of 353), 91.2% (311 of 341), and 97.5% (316 of
324) of infants at the time of birth, 6, 9 and 12 months.
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Characteristics of study population
Table 1 presents the general characteristics of pregnant women during study. Women’s mean
age was 25.9 years (Standard deviation (SD) = 5.4) and 15.7% (63/400) of pregnant women
were primigravidae. During the follow-up, 2.3% (9/400), 55.7% (223/400), 42% (168/400) had
2, 3 and 4 ANC visits, respectively. The mean of estimated pre-pregnancy BMI was 20.8 kg/
m² (SD = 2.7) and 18.7% (75/400) of the mothers were underweight. Among those, 8% (32/
400), 6.5% (26/400) and 4.3% (17/400) presented mild, moderate and severe thinness, respec-
tively. The mean of gestational age at delivery was 39.8 weeks (SD = 1.8). The proportion of
maternal anaemia decreased from 1st ANC to delivery (72.5% to 50%) and 36.9% (145/392) of
women were anaemic during all scheduled visits of pregnancy. Helminth infestations decreased
progressively from the 1st ANC (9.1%) to delivery (5.1%). The proportion of women with a
positive blood smear decreased after IPTp administration (from 16% at 1st ANC to 4.1% at 2nd
ANC), and increased again at delivery (10.8%). Eighty seven pregnant women (22.1%) had a
placental malaria infection at histology evaluation. Infant families’ socio-economic level was
low for 49.3% of the study population.
Table 2 shows the clinical and biological characteristics of the children during the first year
of life. The newborns' mean Hb was 139 g/L (SD = 21) and 46.3% of them were anaemic. New-
borns weighed on average 3033 g (SD = 420.4) and 9.1% (36/400) had a LBW. Only eight chil-
dren (2.4%) had sickle cell disease (genotypes SS and SC). The distribution of Hb
Fig 2. Flowchart diagram of follow-up. Infants who were absent more than 3 consecutive months, and not
seen before their 12 months were considered as lost to follow-up. During the study, five infants (0.1%) were
lost to follow-up and sixteen (0.4%) died. The main reasons of death were: acute respiratory infection (4),
neonatal icterus (1), severe malaria (2), unknown disease (7), congenital biliary atresia (1). Among these
deaths, only 1.2% (2/16) of infants have been bring to hospital by parents.
doi:10.1371/journal.pone.0129510.g002
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concentrations were significantly different between scheduled visits of infant (Kruskal-Wallis
test, P< 0.01). The Hb level decreased from birth to 6 months and remained almost constant
until 12 months (S1 Fig). Anaemia was common in the second half of infancy, exceeding 65%
after 6 months and was significantly dissimilar between the different visits (46.3%, 66.9%,
70.1%, 64.6% at birth, 6, 9 and 12 months of life, respectively; Fisher exact test, P< 0.01). Over
a third of the children presented with ID after 6 months. Malaria infection was common at all
stages of follow-up, around 12%.
Effect of MiP on newborns' Hb concentrations at birth
Children born to malaria-infected mothers tended to present lower Hb concentrations than
children born to non malaria-infected mothers at birth but the association was not significant
(difference of mean Hb (dm) = −1.1 g/L, 95% CI [-3.9, 6.1], P = 0.30). After adjustment, new-
born ferritin level was significantly associated with a decrease in newborns' Hb concentrations
while first pregnancy, Aïzo ethnic group, newborn’s folic acid and vitamin B12 concentrations
were significantly associated with an increase in Hb concentrations at birth (Table 3). Consid-
ering the timing of MiP, malaria infection occurring at 1st ANC, 2nd ANC and delivery were
not statistically associated with newborn Hb at birth (Table 4).
Table 1. General characteristics of pregnant women during study in district of Allada, Benin, 2010–2012.
Characteristics ANC 1* ANC 2* Delivery
No. Mean or % No. Mean or % No. Mean or %
Duration between differents visits (days) 400 - 44.1 (±11.1) 79.7 (±12.7)
Age (years) Mean 400 25.9 (±5.4) - - - -
Gravidity (%) Multigravidae 337 84.3 - - - -
IPTp group (%) SP 138 35.5 - - - -
MQ 262 65.5 - - - -
Estimated pre-pregnancy BMI (%) BMI < 16.0 17 4.3 - - - -
16.0  BMI < 17.0 26 6.5 - - - -
17.0  BMI < 18.5 32 8.0 - - - -
18.5  BMI < 25.0 285 71.2 - - - -
25.0  BMI < 30.0 36 9.0 - - - -
BMI  30.0 4 1.0 - - - -
Gestational age (weeks) Mean 400 22.7 (±3.9) 392 29.2 (±3.7) 397 39.8 (±1.8)
Preterm birth (%) - - - - 397 5.8%
Gestational anaemia (%) Yes 400 72.5 392 67.1 400 50.0
Iron deﬁciency (%) Yes 400 36.5 392 40.1 397 31.5
Folic acid deﬁciency (%) Yes 400 33.7 392 17.1 397 43.5
Vitamin B12 deﬁciency (%) Yes 400 5.3 392 3.6 397 9.3
Helminth infection (%) Yes 395 9.1 387 8.8 355 5.1
Peripheral malaria infection (%) Yes 400 16.0 392 4.1 400 10.8
Placental malaria infection† (%) None - - - - 307 77.9
Past - - - - 45 11.4
Chronic - - - - 33 8.4
Active - - - - 9 2.3
BMI: Body mass index; Preterm birth: gestational age at delivery < 37 weeeks;
IPTp: Intermittent Preventive Treatment in pregnancy against malaria, SP: Sulfadoxine-Pyrimethamine, MQ: Meﬂoquine
* First and second dose of IPTp administrations; Standard deviation are in parentheses
† Malaria infection detected in placenta by histology.
doi:10.1371/journal.pone.0129510.t001
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The relation between the number of maternal anaemia episodes during pregnancy and new-
borns’Hb concentrations was not significant even if a lower Hb concentrations were observed
in infants born to mothers with at least two episodes of anaemia during gestation (dm = −2.6
g/L, 95% CI [-9.6, 4.6] for newborns of women with 2 episodes of anaemia and dm = −4.3 g/L,
95% CI [-11.5, 2.6] for newborns of women with 3 episodes of anaemia, P = 0.35) (Table 3).
Newborns of mothers with more than 3 ANC visits tended to present lower Hb concentra-
tions than those of mothers with less than 3 ANC visits, but the association was not statistically
significant (dm = −1.01 g/L, 95% CI [-5.2, 3.2], P = 0.63).
Effect of MiP on infant Hb levels during the first year of life
Fig 3 shows infants' Hb concentrations variations during the follow-up according to the moth-
ers' malaria status at delivery. Children born to mothers infected by malaria had a lower Hb
concentration than children born to non-infected mothers and this trend persisted throughout
the first year of life. With regard to the effect of MiP timing, only malaria infections occurring
at delivery were significantly associated with a in infant Hb (dm = −4.7 g/L, 95% CI [-8.3, -1.1],
P = 0.01). Malaria infections at 1st and 2nd ANC were not associated with infant Hb modifica-
tion (Table 4).
Table 2. Clinical and biological characteristics of children during the first year of life in district of Allada, Benin 2010–2012, N = 400.
Characteristics At birth At 6 months At 9 months At 12 months
Mean or % Mean or % Mean or % Mean or %
Sex (%) Female 53 - - -
Male 47 - - -
Weight (g) Mean 3033 (±420.4) 7001 (±1001.1) 7705 (±1004.8) 8400 (±1089.1)
LBW (%) 9.1 - - -
Length (cm) Mean 48.9 (±2.43) 66.0 (±3.05) 69.6 (±3.12) 72.5 (±3.44)
MUAC (cm) Mean - 13.8 (±1.44) 14.1 (±2.15) 14.4 (±2.84)
Fever (%) 1.5 16.1 19.8 16.4
Wasting† (%) - 14.6 13.6 9.9
Stunting‡ (%) - 14.3 13.6 16.7
Haemoglobin (g/L) Mean 139.0 (±21.0) 102.1 (±14.8) 102.9 (±14.2) 103.7 (±14.9)
Anaemia¥ (%) 46.3 66.9 70.1 64.6
Mild (100–109) 4.0 31.4 34.7 36.1
Moderate (80–99) 2.7 28.2 29.6 21.5
Severe (< 80) 1.3 7.4 5.8 6.9
Iron deﬁciency (%) 0.5 25.7 38.9 46.2
Folic acid deﬁciency (%) 15.3 10.3 15.3 16.2
Vitamin B12 deﬁciency (%) 3.5 12.9 17.3 14.3
Malaria infection (%) 0 12.1 11.9 12.4
Helminth infection (%) - 3.7 11.9 9.7
Inﬂammation (%) 1.3 24.5 28.8 27.9
Sickle cell disease (%) (SS, SC) - 2.4 - -
MUAC: Mid-upper arm circumference; LBW: Low birthweight (weight < 2500 g); Standard deviation are in parentheses
† Wasting: weight-for-length z-score < -2SD
‡ Stunting: length-for-age z-score < -2SD
¥ Anaemia: haemoglobin < 140 g/L (birth) and < 110 g/L (between 6 and 12 months).
doi:10.1371/journal.pone.0129510.t002
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Multilevel linear regression (Table 5) showed that maternal peripheral parasitaemia at deliv-
ery and placental malaria infection were the main maternal factors to negatively impact on in-
fant Hb concentrations during the first year of life (dm = −4.6 g/L, 95% CI [-7.9, -1.3],
P = 0.007; dm = −2.8 g/L, 95% CI [-5.3, -0.3], P = 0.03; respectively). Low pre-pregnancy BMI,
specifically a severe thinness, was associated with a decrease in Hb concentrations during infan-
cy (dm = −14.8 g/L, 95% CI [-25.9, -3.9], P = 0.05). Others factors to be significantly associated
with a decrease in infant Hb concentrations during the first year of life were the occurrence of
malaria infection during infancy (dm = −11.9 g/L, 95% CI [-14.7, -9.1], P< 0.01), inflammatory
syndrome (dm = −3.9 g/L, 95% CI [-5.8, -1.9], P< 0.01) and fever (dm = −4.1 g/L, 95% CI
[-6.5, -1.7], P< 0.01) at the time of Hb measurement. The number of maternal anaemia epi-
sodes and LBWwere not associated with infant Hb during the first year of life (dm = −0.5 g/L,
95% CI [-1.6, 0.6], P = 0.37; dm = −3.1 g/L, 95% CI [-7.5, 1.2], P = 0.16, respectively).
Population-attributable risks
A total of 11.8% (95% CI = 10.1–13.5%), 9.2% (95% CI = 7.6–10.7%), 7.7% (95% CI = 6.3–
9.1%), 29.8% (95% CI = 27.3–32.3%) of infant anaemia in this population were attributable to
maternal peripheral parasitaemia at delivery, placental malaria infection, maternal under-
weight and malaria infection during infancy, respectively.
Table 3. Factors associated with newborn haemoglobin concentration at birth in district of Allada, Benin 2010–2012, N = 392 (Univariate andmulti-
variate linear regressions).









Placental malaria infection† - 1.1 [-3.9, 6.1] 0.68 - - -
Number of anaemia episode
during pregnancy
1 0.3 [-7.1, 7.6] - - -
2 - 2.6 [-9.6, 4.6] 0.35 - - -
3 - 4.3 [-11.5,
2.6]
- - -




0.02 - - -
Maternal folic acid deﬁciency at
delivery






Aïzo ethnic group 5.1 [0.6, 9.5] 0.03 6.2 [1.7,
10.7]
< 0.01
IPTp group (Meﬂoquine) - 3.2 [-7.6, 1.1] 0.14 - - -
Child’s factors
Serum ferritin level of child at birth
(μg/L)
- 2.6 [-5.2, 0.1] 0.05 - 4.4 [-7.2,
-1.6]
< 0.01
Serum folic acid level of child at
birth (ng/mL)
3.1 [0.2, 6.1] 0.04 3.9 [0.9,
6.9]
0.01
Serum vitamin B12 level of child at
birth (pg/mL)
2.9 [-0.2, 6.2] 0.07 3.7 [0.4,
7.0]
0.03
Sex of child (male) 3.5 [-0.6, 7.7] 0.09 - - -
(-) Association was not signiﬁcant in multivariate analysis; 95% CI: Conﬁdence Interval to 95%
IPTp: Intermittent Preventive Treatment in pregnancy
† Malaria infection detected in placenta by histology (included past, chronic and active infection).
doi:10.1371/journal.pone.0129510.t003
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Table 4. Effect of the timing of maternal peripheral parasitaemia during pregnancy on infant haemoglobin level (g/L) in district of Allada, Benin
2010–2012, by univariate analysis.









Peripheral malaria infection at
ﬁrst ANC
No* 336
Yes 64 - 4.8 [-10.4,
0.8]
0.09 - 0.5 [-3.7,
2.6]
0.74
Peripheral malaria infection at
second ANC
No* 376





Peripheral malaria infection at
delivery
No* 357
Yes 43 - 2.4 [-9.1, 4.2] 0.47 - 4.7 [-8.3,
-1.1]
0.01
ANC: Antenatal clinical visit
† Relationship assessed by linear regression
‡ Relationship assessed by multilevel linear regression (Hb measurement at birth excluded to analysis)
* Baseline category.
doi:10.1371/journal.pone.0129510.t004
Fig 3. Changes of mean haemoglobin level of children during the first year of life according to
mother's malaria status at delivery. Children born to mothers infected by malaria had a lower haemoglobin
concentration than children born to non-infected mothers and this trend persisted during all first year of life.
doi:10.1371/journal.pone.0129510.g003
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Discussion
This study has showed an important reduction of Hb concentrations in Beninese infants born
to mothers with peripheral parasitaemia at delivery or placental malaria infection compared to
infants from uninfected mothers. Our study also found a high prevalence of anaemia through-
out infancy in the study population.
To our knowledge, this is one of the few studies to evaluate the effect of MiP on infant Hb
variations through a one-year follow-up of the newborns in Sub-Saharan Africa (SSA). As Hb
varies physiologically during the first year of life, an important strength of our study was to use
a multilevel linear regression, best adapted to repeated measures to take into account the effect
of time on infants’Hb levels. Our analyses suggested that 65% of the total variance could be ex-
plained by the mixed model. Therefore, this model seems to be well suitable to the analyses of
data. We also recorded few missing data (1.2%) reflecting the good quality of the follow-up.
Furthermore, we were able to take into account potential confounding factors like estimated
pre-pregnancy BMI, infants’malaria infections and nutritional status (iron, folic acid, vitamin
B12) at different times during the follow-up period.
We found that infant’s anaemia was very prevalent in southern Benin, particularly in the
second half of the first year of life (> 65%). These high proportions are consistent with data
from the Beninese Departmental Health and Demographic survey [21]. In our study, the Hb
concentration decreased from birth to 6 months and then remained almost constant until 12
months. This decrease is known as the “physiologic anaemia of the newborn”. After Hb has
reached its lowest level at ~2 months, it slowly increases again and becomes more or less stable
between 6 and 9 months [22].
When we considered the effect of MiP timing, only maternal peripheral parasitaemia at deliv-
ery was significantly associated with decreasing of infant Hb. In our study, malaria infection de-
creased from 1st to 2nd ANC probably because of IPTp efficacy in parasite clearing [23], therefore
the impact of malaria occurring during this period may be reduced by IPTp administration. The
negative effect of maternal peripheral parasitaemia at delivery on infant Hb may also be ex-
plained by the timeframe of IPTp administration. Indeed the duration between the 2nd IPTp
dose and delivery had frequently exceeded two months. Consequently the pregnant women
Table 5. Relation between placental malaria infection or maternal peripheral parasitaemia at delivery and infant haemoglobin level (g/L) during the
first year of life in district of Allada, Benin 2010–2012, N = 337 (multilevel linear regression).
Factors Adjusted† mean Hb difference (g/L) 95% CI P value
Fixed effects*
Maternal peripheral parasitaemia at delivery Reference No
Yes - 4.6 [-7.9, -1.3] 0.007
Placental malaria infection Reference No
Yes - 2.8 [-5.3, -0.3] 0.03
Random effects**
Child-to-child variation (π00) 6.4 [5.3, 7.7] -
Residual variation (σ²) 11.8 [11.1, 12.5] -
Hb: Haemoglobin; 95% CI: Conﬁdence Interval to 95%
† Adjusted for estimation of pre-pregnancy body max index, infant malaria infection, fever episode and inﬂammatory syndrome, acid folic concentration at
birth and infant age
* Estimated by maximum likelihood method
** Estimated by restricted maximum likelihood method.
The intraclass coefﬁcient of Hb variations was estimated at 0.35. Thus, 65% of the total variance could be explained by the model.
doi:10.1371/journal.pone.0129510.t005
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remained insufficiently protected for the last weeks of pregnancy, after the second IPTp dose. A
similar result had previously been reported on Beninese pregnant women, clearly demonstrating
that women who had an early intake of last IPTp dose were more at risk of LBW [24].
Maternal peripheral parasitaemia at delivery and placental malaria infection were the main
maternal factors that contributed to reduce infant Hb concentrations during the first year of
life. Placental malaria is one of the major features of malaria during pregnancy and it has been
widely used as a standard indicator to characterize malaria infection in epidemiological investi-
gations [25,26]. Moreover, placental histology used to assess MiP is considered as the "gold
standard" of malaria diagnosis in pregnancy for epidemiological or biological study purposes,
because it can show signs of active, chronic or past infections [13,27].
The biological explanation of the effect of MiP on infant anaemia in this study is complex
to establish. Infant anaemia may be indirectly due to a higher susceptibility to malaria, a well-
known risk factor for anaemia in itself. Two potential mechanisms can be evoked. First, envi-
ronmental factors are likely to play a role, as women infected by malaria at delivery may have
been more exposed to anopheles bites during pregnancy than uninfected women. Because
mothers infected by malaria parasites and their children live in the same area, the latter may
also be more exposed to the risk of malaria, one of the most important causes of infants' anae-
mia. Secondly, an immune tolerance phenomenon can also be involved, a very likely mecha-
nism, as in the analysis of our dataset the relationship between MiP and decrease of infant's
Hb persisted after adjusting on infant malaria infection throughout the first year of life. In a re-
cent study on a similar population in Benin, Le Port et al. showed that first malaria infections
in early childhood could be attributed independently to both placental malaria and high levels
of exposure to infected anopheles [9]. In the same area, Rachas et al. showed that placental ma-
laria infection was strongly associated with an increased risk of non-malaria fever episodes as
well as gastrointestinal and respiratory febrile syndromes [28]. It can be assumed that the se-
questration of malaria parasites in the placenta allows in-utero exposure of the fetus to a varie-
ty of malaria antigens that may induce immunological tolerance [29] and thus increase the
susceptibility of infants to subsequent malaria infections [30]. Such immune tolerance could
be responsible for the development of a tolerogenic environment, involving a number of im-
mune effectors [31,32] potentially interacting with the development of immunity during the
first year of life. Such interactions concern not only the malaria-specific immune response but
also general immunity.
Earlier reports from Malawi and Cameroon had previously suggested a relation between
placental malaria and infant Hb status. Redd et al. (1994) in Malawi had assumed that placental
malaria infection might interfere with the hematologic status of the infant independently of
birth weight and prematurity [33]. Cornet et al. (1998) had also reported that placental malaria
infection was the strongest risk factor for anaemia in six-month-old children in southern Cam-
eroon [34]. These studies have also suggested that physical alterations of the trophoblastic
membrane due to malaria infection could decrease nutritional exchanges, such as iron, folate,
and vitamin B12, between the mother and the fetus [35].
Our study suggests that children born to mothers with a very low BMI at the beginning of
pregnancy (< 16 kg/m²) had a lower Hb concentration than children born to mothers with a
normal BMI. It is also the first time that this relation is described. The low BMI reflects the ma-
ternal under-nutrition and could be a proxy of future infant's nutrition. Indeed, children born
to underweight mothers may have a poor diet and therefore may be at higher risk of anaemia.
Furthermore, underweight and stunted women are at high risk of delivering premature or
LBW infants, who in turn, are at high risk of poor growth and anaemia in childhood and ado-
lescence [36]. Indeed in our study, infants born to mothers with a BMI< 20 kg/m² had a 2.1
fold increased risk of LBW (95% CI [1.04–4.19], p = 0.04).
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The number of maternal anaemia episodes during pregnancy was not associated with infant
Hb concentration at birth and during the first year of life. It may seem surprising but similar re-
sults have been reported in Malawi [37], which may partially be explained by the fetal regula-
tion of iron transport during pregnancy. A hierarchy in the use of iron in pregnancy has been
suggested: fetus has priority over maternal iron stores [38]. An infant may be born with ade-
quate iron stores though the mother stays moderately anemic during pregnancy. But according
to Gambling et al., this mechanism also depends on the intensity of maternal iron depletion
(below 200 μg/g, the maternal liver responds to the iron deficiency and tries to restore its own
concentrations of iron). In our study, we have only considered the number of anaemia episodes
detected at IPTp administrations and this may not necessarily reflect the history of maternal
anaemia during all pregnancy duration. Indeed, by studying repeated measures of Hb on a larg-
er sample size (1005 mother-infant pairs) and by using a path analysis, Ouédraogo et al. found
a direct, though border-line, association of maternal anaemia in the third trimester and new-
born's hemoglobin level at birth (personal communication).
Malaria infection, fever and inflammatory syndrome in children at the time of Hb measure-
ment were significantly associated with a decrease in infant Hb concentrations probably due to
hemolytic anaemia. The association of anaemia with fever or inflammatory syndrome under-
lines the important contribution of infections in the occurrence of infant anaemia during the
first months of life and the potential causes of inflammation in pregnancy as well as in infancy
hence deserve further studies.
This study has some limitations that should be considered. First, the absence of entomologi-
cal data in our study such as the level of anopheles transmission did not allow the determina-
tion of the part of malaria risk attributable to a common exposure of the mother and her child
to malaria vectors, even if the results rather suggest an effect of placental parasite sequestration
on the immune tolerance of child. Second, the maternal nutritional status was assessed by BMI
and weight was calculated approximately on the assumption of a 1kg/month gain from the end
of the first trimester, which may not reflect correctly the nutritional status of women at the be-
ginning of pregnancy because of the difference of weight gain from underweight to obese [39].
Further studies actually taking into account the nutritional status before pregnancy seem nec-
essary to confirm our result on the relation between lower maternal BMI and the infant Hb
during the first year of life. And finally, fundal height measurement by bimanual palpation was
probably not the most suitable and accurate way to evaluate gestational age during pregnancy
and may be the source of some imprecision in our final results.
Conclusion
Anaemia in infancy is very common in Benin. In the present study, MiP and malaria infection
during infancy were independently associated with a substantial reduction in infant Hb during
the first year of life. Low maternal BMI at the beginning of pregnancy was also related to a de-
crease in infants' Hb. Strategies to prevent anaemia in infants should as well integrate measures
during pregnancy such as the prevention of MiP and the improvement of maternal nutritional
status. IPTp and the use of bed nets by both mothers and infants should be reinforced. Micro-
nutrient supplementation should also be implemented in women of childbearing age and preg-
nant women but with a lot of caution in a context of malaria-iron interactions where the
protection of iron deficiency against malaria is still a controversial issue [40,41].
Supporting Information
S1 Fig. Haemoglobin variation in Beninese infants during the fisrt year of life. During the
first months of life, haemoglobin level declines from very high level at birth to its lowest level at
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2–3 months of age. This decrease is known as the “physiologic anaemia of the newborn”. After
Hb has reached its lowest level at ~2 months, it slowly increases again and becomes more or
less stable between 6 and 9 months.
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